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cross-sectional analysis of 2005–2006 MEPS data involving children. Functional 
impairment was ascertained using the mean summated scores (range 0–52) of the 
parent-reported Columbia Impairment scale (CIS). Psychometric properties of the CIS 
were evaluated for the study sample. The Wilson and Cleary Model was used to 
examine the factors associated with functional impairment in children and adolescents. 
The primary independent variable of interest was depression. Multivariate linear 
regression involving the SURVEYREG procedure was applied to the study sample to 
identify the predictors of functional impairment in children and adolescents. 
RESULTS: Analysis of the CIS revealed that Cronbach’s alpha of the parent-reported 
CIS was 0.90 with item-to-total correlations ranging from 0.51 to 0.77. The mean 
summated CIS score of children and adolescents with depression (CIS, 19.88) was 
higher than those without depression (CIS, 6.09). Multivariate linear regression 
revealed that the interaction between age and depression was signiﬁcant and therefore 
stratiﬁed regression analysis was performed by age. In both age groups, the diagnosis 
of depression was strongly associated with functional impairment (+7 units in ages 
5–11 years, +11 units in ages 12–17 years). The presence of developmental, respiratory 
tract, attention deﬁcit, and anxiety disorders also increased functional impairment in 
children and adolescents. Family factors such as parents’ psychiatric illness, their 
highest education level and family living arrangement further contributed to impair-
ment in children. CONCLUSIONS: Functional impairment is signiﬁcant in pediatric 
depression and understanding of personal and family factors can play an important 
role in the assessment, management and treatment of depression.
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OBJECTIVES: Previous research has demonstrated that clear thinking is relevant to 
patients diagnosed with schizophrenia. We tested the reliability and validity of an 
experimental clear thinking scale (CTS) among a sample of outpatients diagnosed with 
schizophrenia. The CTS measures functioning across four sub-domains: staying orga-
nized (SO); making sense of the world (MS); feeling clear headed (CH); and expressing 
thoughts and feelings (TF). METHODS: Following item generation and reduction, 
cognitive interview were used to reﬁne the survey instrument. The scale was then 
ﬁelded to a sample of outpatients diagnosed with schizophrenia. The reliability and 
validity of the CTS and its four sub-domains was assessed using the Cronbach’s alpha 
and comparison to the Clyde mood scale (CMS) construct of “clear thinking”. 
RESULTS: Cognitive interviews (n = 12) identiﬁed several items that patients had 
difﬁculty understanding, which were subsequently removed or reworded. We also 
found that all items needed to be unidirectional and measuring deﬁcits (i.e., while clear 
thinking is a positive construct, patients related to it best in its absence). A sample of 
51 outpatients diagnosed with schizophrenia (66% male; average age = 49 y; average 
time since diagnosis = 22 y) completed the survey (only one respondent was unable 
to complete the survey. Cronbach’s alphas for all constructs were good: .77 (SO), .79 
(MS) .79 (CH), and .83 (TF), and was excellent for the overall scale (.93). All con-
structs were positively correlated with CMS clear thinking construct, which had a 
Cronbach’s alpha of .8, but these correlations were signiﬁcant only for TF (p = 0.002) 
and the overall scale (p = 0.02). CONCLUSIONS: Findings indicate that clear thinking 
can be reliably and validly described over four domains that are relevant to patients 
diagnosed with schizophrenia. Future research will focus on further reﬁning the CTS, 
comparing it with other scales of functioning and disease symptoms and assessing its 
sensitivity to changes.
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OBJECTIVES: To analyze a variety of variables for DRG 427, non-depressive neuro-
ses, in comparison to the control group to determine any trends or discrepancies. 
METHODS: The data were taken from the Kids’ Inpatient Database (KID) from year 
2007. This database describes hospital inpatient stays for children. To create a control 
group for comparison, a random sample of 8201 patients with DRG codes other than 
427 was taken. The control group combined with the experimental group, DRG code 
427, gives a total of 16,402 entries to examine. RESULTS: The diagnosis of non-
depressive neuroses was found to be much more prevalent in females than males. 
While the general inpatient group was only 47% female, the speciﬁc DRG group was 
57% female. Kernel density estimations revealed that the speciﬁc DRG group on 
average had shorter lengths of stay and lower total charges than the general inpatient 
group. A logistic regression performed showed that patient demographics and severity 
levels are all signiﬁcant in predicting whether a patient will be classiﬁed as general 
inpatient group or speciﬁc DRG group. Linear regressions also showed that both the 
APRDRG and Disease Staging Resource Demand severity indices are signiﬁcant in 
predicting a patient’s total charges and length of stay. A linear regression using the 
top 10 diagnosis and procedure codes to predict length of stay showed that these 
variables predict very little of the variability. CONCLUSIONS: From the initial sta-
tistical analyses, it is evident that the experimental group had more females than males 
and on average showed shorter lengths of stay and charges than the control group. 
Also, severity levels proved to be consistently signiﬁcant in predicting the control, 
length of stay, and total charges while patient demographics and diagnosis and pro-
cedure codes were only signiﬁcant in some models.
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OBJECTIVES: To conduct exploratory data analysis on DRG 521: alcohol/drug abuse 
or dependence with complications and comorbidities. Comparing DRG 521 to a 
control group will provide insights into statistical trends relating to this particular 
diagnosis. METHODS: The data used for this statistical analysis were obtained from 
The Kids’ Inpatient Database (KID) from 2007. KID is a national database containing 
information on hospital inpatient stays for children twenty years old and younger. In 
this database, there are 1,447 cases of DRG 521. For comparison purposes, a random 
sample equal in size was drawn from all DRG codes other than DRG 521. The statisti-
cal software, SAS, is used to analyze this data set. RESULTS: Initial statistical analyses 
have shown a greater proportion of whites in the experimental group (DRG 521), 
72%, compared to the control group with 61%. The overwhelming majority of the 
experimental group is in the higher age range of ﬁfteen to twenty years old, compared 
to the control group which has a uniform distribution across all ages. In addition, the 
experimental group contains a higher proportion of males, 55.8%, compared to the 
control group, 52%. CONCLUSIONS: Previous research has indicated that when 
individuals have comorbid conditions including drug/alcohol dependence and mental 
illnesses, males are more likely to be treated and seek treatment for substance depen-
dence whereas females are more likely to seek treatment for mental illnesses. This 
information could explain why more males are present in the experimental 
group,compared to the control group. In addition, adolescence and young adults are 
more likely to engage in risky behavior, which would explain the concentration of 
older individuals in the experimental group.
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OBJECTIVES: The objective of this study is to compare rates of hospitalization among 
patients receiving different classes of antipsychotics (SGAs, FGAs, both, or none) in 
a large, all-ages sample of both institutionalized and noninstutionalized Medicare 
beneﬁciaries. METHODS: We examined the 2005 Medicare Current Beneﬁciary 
Survey (MCBS) Cost and Use ﬁle Prescription Drug Event (PDE) module for 11,236 
survey participants. Antipsychotic utilization was characterized in terms of class: FGA 
(chlorpromazine, ﬂuphenazine, haloperidol, loxapine, perphenazine, thiothixene, thio-
ridazine, and triﬂuoperazine) or SGA (aripiprazole, clozapine, olanzapine, quetiapine, 
risperidone, and ziprasidone). Hospitalization was deﬁned in terms of whether a 
Medicare beneﬁciary was admitted to the hospital for any reason in 2005, and the 
number of hospital visits. RESULTS: About 3.5% of Medicare beneﬁciaries (1.3 
million) ﬁlled one or more prescriptions for an antipsychotic medication in 2005. 
Rates of all-cause hospitalization among Medicare beneﬁciaries were signiﬁcantly 
higher for SGA users than for FGA users: 38.9% of those who used only SGAs com-
pared to 31.0% of FGA-only users. Patients prescribed both FGAs and SGAs had the 
highest rate of hospitalization (60.7%), compared to 21.3% of nonusers. Controlling 
for demographic, socioeconomic, health, and disability variables, SGA users were over 
twice as likely (odds ratio, 2.2; 95% CI, 1.17–2.9), and combination users were over 
six times as likely (odds ratio, 6.3; 95% CI, 2.4–16.2) as nonusers to be hospitalized. 
The odds of FGA users being hospitalized were not signiﬁcantly different from nonus-
ers (odds ratio, 1.4; 95% CI, 0.7–2.8). CONCLUSIONS: This analysis offers provoca-
tive, but by no means conclusive evidence that SGAs as a class are not necessarily 
superior to FGAs in mitigating patient’s use of hospital services, Systematic analysis 
of this relationship with a longitudinal sample of Medicare beneﬁciaries is 
warranted.
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OBJECTIVES: The majority of antipsychotic use in the elderly is to treat behavioural 
and psychological symptoms of dementia. New information on the safety of antipsy-
chotics in the elderly was released between 2000 and 2005. This analysis provides 
insight into antipsychotic use among seniors during this time period. METHODS: 
Claims level data from the National Prescription Drug Utilization Information System 
(NPDUIS) Database were analyzed for seniors on public drug programs in six Cana-
dian provinces between 2001–2002 and 2006–2007. This analysis looked at trends in 
antipsychotic use, including use by age and sex. Additional analyses focused on atypi-
